Tuesday, March 8, 2011

RegenMD - UC Davis launches stem cell study to reduce amputations from vascular disease ...

     
    RegenMD    
   
UC Davis launches stem cell study to reduce amputations from vascular disease ...
March 8, 2011 at 11:12 PM
 
The cells are also tested for sterility and quality in the new UC Davis Good Manufacturing Practice Facility that was funded by the California Institute for Regenerative Medicine (CIRM). "The hope is that what these cells do in the very early stages of ...
See all stories on this topic »
   
   
Lab-grown Urethras Successfully Grafted in Humans
March 8, 2011 at 6:58 PM
 
"We were able to create patients' own tissue that actually belongs there," said lead author of the research, Dr. Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine. ...
See all stories on this topic »

Health Aim
   
   
Regenerative medicine program at U of M first of its kind in Western Canada
March 8, 2011 at 4:48 PM
 
Researchers in the field of regenerative medicine at the University of Manitoba will soon be able to conduct their work in a new facility, following significant investments from the federal government. The regenerative medicine program at the U of M is ...
See all stories on this topic »

Manitoban
   
   
Foals' umbilical cords can be banked for future stem-cell treatments
March 8, 2011 at 2:45 PM
 
Horse owners now have the opportunity to collect umbilical cord tissue immediately after a foal is born and save it as a future source of therapeutic stem cells through the Regenerative Medicine Laboratory at UC Davis' School of Veterinary Medicine. ...
See all stories on this topic »
   
   
California Stem Cell Agency Ventures into Publishing
March 8, 2011 at 1:07 PM
 
   
   
First Lab-Grown Urethras Succeed
March 8, 2011 at 11:27 AM
 
By Rob Quinn, Newser Staff (Newser) – The field of regenerative medicine has chalked up a major success. Scientists have successfully grown urethras in the lab using patients' own cells, and the urinary tubes are still functioning normally six years ...
See all stories on this topic »
   
   
Urethra grown from patient's own cells: What next from "regenerative medicine?"
March 8, 2011 at 11:27 AM
 
That's the promise of a new study from the fast-growing field of regenerative medicine, in which doctors successfully repaired injured urinary tracts using "urine tubes" made from cells taken from the patients' own bladders. Beginning in 1998, a team ...
See all stories on this topic »

CBS News
   
   
Regenerative medicine breakthroughs
March 8, 2011 at 8:07 AM
 
By Office of Communications and External Relations The work being done in the field of regenerative medicine at Wake Forest University Baptist Medical Center, led by Dr. Anthony Atala, was in the news this week: A team at Wake Forest University Baptist ...
See all stories on this topic »
   
   
Fibrocell Science, Inc. Announces Scientific Collaboration with UCLA on ...
March 8, 2011 at 8:07 AM
 
[He conducts his research at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.] Dr. Byrne is an expert in both human genetics and nuclear reprogramming. He completed his Bachelor of Science degree in human genetics at ...
See all stories on this topic »
   
   
New Method Improves Mechanical Properties of Polymeric Bone Scaffolds
March 8, 2011 at 7:24 AM
 
So, the new subject of 'bone tissue engineering' is proposed and its application with nanotechnology made it possible to approach the natural structure of bone," Arjang Hamleh-Khan, MS. in medical engineering, said. "For this purpose, we conducted a ...
See all stories on this topic »
   
   
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia.
March 8, 2011 at 5:39 AM
 

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia.

Circulation. 2011 Jan 25;123(3):282-91

Authors: Caporali A, Meloni M, Völlenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C

Diabetes mellitus impairs endothelial cell (EC) function and postischemic reparative neovascularization by molecular mechanisms that are not fully understood. microRNAs negatively regulate the expression of target genes mainly by interaction in their 3' untranslated region.

PMID: 21220732 [PubMed - indexed for MEDLINE]

   
     
 
This email was sent to agupta1213+termsc@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: